FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

Size: px
Start display at page:

Download "FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)"

Transcription

1 FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du) Course BioPharmaceuticals and Advanced Therapies 28-2 September/October Auditorium The FCT PhD Programme in Medicines and Pharmaceutical Innovation (i3du) trains students in target discovery, drug design, pre-clinical development, and drug safety, bridging the translational gap from discoveries on disease targets and mechanisms into novel diagnostic and therapeutic agents. The i3du Programme offers a training course that will be held at the Research Institute for Medicines (), Faculdade de Farmácia, Universidade de Lisboa, in Lisbon, 28-2 September/October Course outline The course on Biopharmaceuticals and Advanced Therapies covers critical aspects of biopharmaceuticals and advanced therapies from discovery methods to development of therapies, with emphasis on success cases of antibodies, gene therapy and cell therapy. The aim of this training course is to delivery not only state-of-the-art information but also to give training on the different aspects of biopharmaceuticals. As the functions of biopharmaceuticals are fully explored and utilised, they will become increasingly relevant to the drug development community. The training program welcomes the participation of external academic and scientific community members. Registration is free but mandatory. Organizing committee João Gonçalves, / FFULisboa (Coordinator) Sofia Corte-Real, TechnoPhage Mariana Santa-Marta, / FFULisboa Paula Brito, / FFULisboa 1

2 Discovery of Biopharmaceutical proteins September 28, 2015 Different classes of biopharmaceuticals João Gonçalves In vivo models for biopharmaceutical discovery António Duarte Faculdade de Medicina Veterinária, Universidade de Lisboa Sea as a source of biopharmaceutical leads Helena Vieira Faculdade de Ciências, Universidade de Lisboa Why use Zebrafish as a discovery model for biopharmaceuticals? Sara Sousa TechnoPhage Regulatory overview of biologic advanced therapies Margarida Menezes Infarmed 2

3 Biopharmaceuticals: the success case-study of antibody therapy September 29, 2015 The discover methodology of therapeutic antibodies Diana Ramos FairJourney Biologics Oporto, Portugal Alternative antibody scaffolds for therapy Soraia Oliveira TechnoPhage Chemical Biology and Antibody Drug Conjugates Pedro Góis Therapeutic Antibodies for autoimmunity/inflammation João Eurico Instituto de Medicina Molecular Faculdade de Medicina, Universidade de Lisboa Therapeutic Antibodies for cancer João Gonçalves 3

4 Methodology for Development of Biopharmaceutical medicines September 30, 2015 Production methodologies for biopharmaceuticals and regulatory environment Maria Henriques Ribeiro Formulation of biopharmaceuticals Helena Florindo Pre-clinical trials for biopharmaceuticals Sofia Corte-Real TechnoPhage How to setup and analyze data from clinical trials? António Mata Faculdade de Medicina Dentária, Universidade de Lisboa How biopharmaceutical quality influences safety and efficacy of biopharmaceuticals John Milne National Institute for Biologic Research and Training Ireland 4

5 Advanced Biologic Therapies October 1, 2015 Pharmacokinetics of therapeutic proteins Nuno Elvas Immunogenicity of therapeutic proteins Joana Costa Instituto de Biologia Molecular e Celular Faculdade de Medicina da Universidade do Porto Oporto, Portugal Gene therapy with viral and non-viral vectors Gabriela Silva Centro de Estudos de Doenças Crónicas Faculdade de Ciências Médicas da Universidade Nova de Lisboa Can Phages be biopharmaceuticals? Madalena Pimentel From Bench to patient with cell therapy Afonso Almeida Instituto de Medicina Molecular, Universidade de Lisboa 5

6 The industry view of Biopharmaceuticals October 2, 2015 Worldwide Development of Biosimilars António Silva Sandoz Biopharmaceuticals Austria Differentiation of Human Mesenchymal stromal/stem cells and applications in therapy Pedro Cruz ECBio Portugal How to bring value in the competitive market of biopharmaceutical production Teresa Alves GenIbet Portugal Market access of biopharmaceuticals: The end of the line? Carla Paixão Roche Farmacêutica Portugal Discovery and Development at Centers for Therapeutic Innovation (CTI) Isaac Rondon Pfizer Inc. USA 6

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du) FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du) Course ADVANCED DRUG DELIVERY March 14-18, 2016 Amphiteater B Lisbon, Portugal The FCT PhD Programme in Medicines and Pharmaceutical Innovation

More information

Research and Education

Research and Education Research and Education who are we The metropolitan university of Lisbon Lisbon, Almada, Oeiras and Cascais (future) 40 years old (founded in 1973) 9 academic units Faculdade de Ciências e Tecnologia Faculdade

More information

training programme in pharmaceutical medicine Regulatory affairs

training programme in pharmaceutical medicine Regulatory affairs training programme in pharmaceutical medicine Regulatory affairs INFARMED, Lisbon 19-21 january 2012 Regulatory affairs 19 21 january 2012 LocaL: INFARMED, Lisbon curricular unit Leader: Hélder Mota Filipe,

More information

I Advanced Course Clinical and Molecular Virology

I Advanced Course Clinical and Molecular Virology 2 nd announcement I Advanced Course Clinical and Molecular Virology 9-20 May 2016 Porto, Portugal Scientific/Organizing Commitee Hugo Sousa (Virology Service, IPO Porto, Porto PT) Rui Medeiros (Virology

More information

International Scientific Cooperation in Neglected Tropical Diseases: Portuguese Participation in EDCTP-2

International Scientific Cooperation in Neglected Tropical Diseases: Portuguese Participation in EDCTP-2 International Scientific Cooperation in Neglected Tropical Diseases: Portuguese Participation in EDCTP-2 Ricardo Pereira 31 October 2013 Fundação Calouste Gulbenkian, Lisboa Table of Contents 1. Overview

More information

Statistical and Narrative Report

Statistical and Narrative Report Statistical and Narrative Report Program: Portuguese Scholars and Researchers AY: 2016/2017 FY: 2016 Officer in charge: Paula Lemos Date of report: February 4, 2016 Contents 1. Brief description of the

More information

PRODUCT RESEARCH & DEVELOPMENT PROCESS

PRODUCT RESEARCH & DEVELOPMENT PROCESS 0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PHARMATRAIN CENTRE OF EXCELLENCE INTRODUCTORY MODULE: PRODUCT RESEARCH & DEVELOPMENT PROCESS Aveiro

More information

Programme for Advanced Medical Education (Doctoral Programme for Physicians)

Programme for Advanced Medical Education (Doctoral Programme for Physicians) Programme for Advanced Medical Education (Doctoral Programme for Physicians) 2011-2012 4 th Edition 1 Programme for Advanced Medical Education The reasons Contemporary Biomedical science provides clinical

More information

FACULDADE DE FARMÁCIA UNIVERSIDADE DE LISBOA

FACULDADE DE FARMÁCIA UNIVERSIDADE DE LISBOA FACULDADE DE FARMÁCIA UNIVERSIDADE DE LISBOA MASTER COURSE BIOPHARMACEUTICAL SCIENCES POST-GRADUATED SPECIALIZATION COURSE Accredited by Agência de Avaliação e Acreditação do Ensino Superior (A3ES) 7 th

More information

Portuguese Research Institutions in History

Portuguese Research Institutions in History José Luís Cardoso Technical University of Lisbon jcardoso@iseg.utt.pt Luís Adão da Fonseca University of Porto lfonseca@letras.up.pt The growth in historical research in Portugal over the last two decades

More information

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right

More information

Low Back Pain and Fibromyalgia: EpiReumaPt survey results

Low Back Pain and Fibromyalgia: EpiReumaPt survey results Gouveia N(1), Rodrigues A(2), Mendonça S (3), Costa LP(4), Canhão H(5), Branco JC(6) 1 EpiReumaPt Investigation Team - Sociedade Portuguesa de Reumatologia 2 Rheumatology Research Unit, Instituto de Medicina

More information

Europass Curriculum Vitae

Europass Curriculum Vitae Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address(es) dos Santos Rua Manuel Bernardes, n.º 29-A r/c 1200-251 Lisboa Telephone(s) (+351) 96 508 51 32 Fax(es) E-mail anacatarinasalves@gmail.com

More information

From Drug Discovery to First in Humans

From Drug Discovery to First in Humans 0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PharmaTrain Centre of Excellence Non-Clinical Testing, Pharmaceutical & Early Clinical Development:

More information

Dr.ssa Maria Luisa Nolli CEO

Dr.ssa Maria Luisa Nolli CEO IL RUOLO DELLE PICCOLE E MEDIE INDUSTRIE NELLA PROMOZIONE DELLA MEDICINA TRASLAZIONALE Quality and Innovation Dr.ssa Maria Luisa Nolli CEO INTRODUCTION ARETA INTERNATIONAL 12 years of experience in contract

More information

Drug Safety of Stem Cells and other Novel Therapeutics

Drug Safety of Stem Cells and other Novel Therapeutics Course 1.2 Drug Safety of Stem Cells and other Novel Therapeutics 13 17 October 2014 MRC Centre for Drug Safety Science Institute of Translational Medicine University of Liverpool, Liverpool, UK European

More information

Quality and Safety Evaluation of Gene Therapy Products in Japan

Quality and Safety Evaluation of Gene Therapy Products in Japan Quality and Safety Evaluation of Gene Therapy Products in Japan Review Mechanism for Gene Therapy in Japan The review mechanism for gene therapy in Japan was partially amended to simplify the necessary

More information

CITIES AND CLIMATE CHANGE PROGRAMME

CITIES AND CLIMATE CHANGE PROGRAMME CITIES AND CLIMATE CHANGE PROGRAMME International Conference Lisbon Portugal 15-16 May 2008 Centre of Geographical Studies University of Lisbon Organization Committee: Maria João Alcoforado Henrique Andrade

More information

APIFARMA PORTUGUESE PHARMACEUTICAL INDUSTRY ASSOCIATION

APIFARMA PORTUGUESE PHARMACEUTICAL INDUSTRY ASSOCIATION APIFARMA PORTUGUESE PHARMACEUTICAL INDUSTRY ASSOCIATION 2015 ABOUT US Portuguese Pharmaceutical Industry Association Founded in 1975, succeeds the National Guild of the Manufacturers of Medicinal Products

More information

PRINCIPLES AND PRACTICES OF MEDICAL DEVICE DEVELOPMENT

PRINCIPLES AND PRACTICES OF MEDICAL DEVICE DEVELOPMENT 0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PHARMATRAIN CENTRE OF EXCELLENCE PRINCIPLES AND PRACTICES OF MEDICAL DEVICE DEVELOPMENT Lisbon,

More information

PharmaceuticalDevelopment

PharmaceuticalDevelopment PharmaceuticalDevelopment Activities & Timelines Agenda Factors driving development Types of product Timelines for development Factors affecting length of development Regulation of Pharma environment Cost

More information

Article 53(c) EPC - therapy

Article 53(c) EPC - therapy Article 53(c) EPC - therapy Compound X is not new, but no medical use (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) compound X for use as a medicament compound X for use in treating disease Y composition

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

SPS Sustainability Performance Assessment and Benchmarking Framework of The Public Sector

SPS Sustainability Performance Assessment and Benchmarking Framework of The Public Sector Seminário Avaliação de Desempenho e Benchmarking de Sustentabilidade no Setor Público Lisboa, 10 de janeiro de 2013 Fundação Calouste Gulbenkian, Sala 2 Organização Apoio Media Partner SPS Sustainability

More information

Orthogonal ray imaging: from dose monitoring in external beam therapy to low-dose morphologic imaging with scanned megavoltage X-rays

Orthogonal ray imaging: from dose monitoring in external beam therapy to low-dose morphologic imaging with scanned megavoltage X-rays ray imaging: from dose monitoring in external beam therapy to low-dose morphologic imaging with scanned megavoltage X-rays Hugo Simões, Miguel Capela, Ana Cavaco, Paulo Fonte, Maria do Carmo Lopes, Paulo

More information

Presentation of Nova Doctoral School why, what for and how. João Crespo

Presentation of Nova Doctoral School why, what for and how. João Crespo Opening Day Presentation of Nova Doctoral School why, what for and how João Crespo Why and what for Tomorrow is not what it used to be Paul Valery encourage curiosity encourage risk taking non-linear

More information

Last year we started with: Workshop One: Year One July 2015: Natural Cork - Tradition: Gain an appreciation and understanding Cork as a material.

Last year we started with: Workshop One: Year One July 2015: Natural Cork - Tradition: Gain an appreciation and understanding Cork as a material. Impact of Material Technologies and Applications WORKSHOP SCOPE The creation of an international workshop focussed on the use of cork material in architecture. It will provide an environment for researchers,

More information

exactly. The need for efficiency in developing effective new therapeutics has never been greater.

exactly. The need for efficiency in developing effective new therapeutics has never been greater. exactly. The need for efficiency in developing effective new therapeutics has never been greater. As demands on the global healthcare system increase and treating disease becomes more complex, the research,

More information

Life Science Sector Opportunities Northern Ireland. Clinical Trials. investni.com

Life Science Sector Opportunities Northern Ireland. Clinical Trials. investni.com Life Science Sector Opportunities Northern Ireland investni.com Introduction Clinical trials commonly refer to testing the effectiveness of experimental drugs and are typically categorised into four phases;

More information

FACT SHEET 2010/2011 FCEE-Católica International Office

FACT SHEET 2010/2011 FCEE-Católica International Office Catholic University of Portugal The School of Economics and Management FACT SHEET 2010/2011 FCEE-Católica International Office Address The School of Economics and Management Catholic University of Portugal

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

THE CENTRE FOR PHARMACEUTICAL ONCOLOGY

THE CENTRE FOR PHARMACEUTICAL ONCOLOGY THE CENTRE FOR PHARMACEUTICAL ONCOLOGY Application for Membership Send Completed Form to: sam.dalfonso@utoronto.ca Name (Last, First): Current Position: o Professor o Associate Professor o Assistant Professor

More information

LIST OF ATTORNEYS. Maio Island

LIST OF ATTORNEYS. Maio Island LIST OF ATTORNEYS Although these attorneys have been chosen with care, the Embassy cannot be responsible for their ability nor can the Embassy accept any financial responsibility. Their names are arranged

More information

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES

More information

From Research Services and Process Development to GMP Manufacturing

From Research Services and Process Development to GMP Manufacturing From Research Services and Process Development to GMP Manufacturing P a r ag o n B i o s e r v i c e s, I n c. A contract research and GMP manufacturing organization (CMO) with a focus on the development

More information

OCT Practical Aspects of Conducting Clinical Trials for Russian Innovative Companies

OCT Practical Aspects of Conducting Clinical Trials for Russian Innovative Companies OCT Practical Aspects of Conducting Clinical Trials for Russian Innovative Companies Innovative Drug Research and Development in Russia 2012 OCT: CRO in Russia, Central and Eastern Europe Russian Innovative

More information

Biomedical Accelerator Fund. Office of Technology Development Harvard University

Biomedical Accelerator Fund. Office of Technology Development Harvard University Biomedical Accelerator Fund Office of Technology Development Harvard University Curtis Keith, Chief Scientific Officer May 21, 2012 Mission of Harvard s Office 2 Organizational Structure of Harvard OTD

More information

Clinical trials preclinical requirements. Clinical trials - legislation

Clinical trials preclinical requirements. Clinical trials - legislation Clinical trials preclinical requirements Mikael Andersson, PhD Senior Expert Medical Products Agency, Sweden Tallinn 9/10 2009 Clinical trials - legislation Directive 2001/20/EC Clinical trial directive

More information

Mónica Isabel Gonçalves Carvalheira

Mónica Isabel Gonçalves Carvalheira Mónica Isabel Gonçalves Carvalheira Personal Data Place and Date of Birth: Portugal, 03 January 1984 Address: Rua Maria Machado nº 103ºA, 2650-187 Amadora Phone: +351 933926231 Email: mic16141@campus.fct.unl.pt

More information

4th LISBON VASCULAR FORUM 4º FORUM VASCULAR DE LISBOA. LISBON MARRIOTT HOTEL 13 and 14 DECEMBER 2013 PROGRAMA PRELIMINAR PRELIMINARY PROGRAM

4th LISBON VASCULAR FORUM 4º FORUM VASCULAR DE LISBOA. LISBON MARRIOTT HOTEL 13 and 14 DECEMBER 2013 PROGRAMA PRELIMINAR PRELIMINARY PROGRAM 4th LISBON VASCULAR FORUM 4º FORUM VASCULAR DE LISBOA LISBON MARRIOTT HOTEL 13 and 14 DECEMBER 2013 PROGRAMA PRELIMINAR PRELIMINARY PROGRAM SERVIÇO DE CIRURGIA VASCULAR / CLÍNICA UNIVERSITÁRIA HOSPITAL

More information

Making the most of academic drug target discoveries

Making the most of academic drug target discoveries Making the most of academic drug target discoveries Richard Reschen, Isis Innovation, University of Oxford The explosion of new technologies and research techniques, and encouragement from funding agencies

More information

Alterações empresariais sustentadas pelo conceito de engenharia do Produto Patrício Soares da Silva, MD, PhD

Alterações empresariais sustentadas pelo conceito de engenharia do Produto Patrício Soares da Silva, MD, PhD Alterações empresariais sustentadas pelo conceito de engenharia do Produto Patrício Soares da Silva, MD, PhD 1 Summary Hypothesis Generation Candidate Development Commercialization Target Identification

More information

From The Lab To Your Medicine Cabinet:

From The Lab To Your Medicine Cabinet: From The Lab To Your Medicine Cabinet: A Pharmaceutical Drug s Journey Presented by: Dr. Steven Hansel Sr. Director; Pfizer Moderated by: Sam Gilchrist Ph.D. Candidate; UBC The Drug Development Process

More information

Course Curriculum for Master Degree in Clinical Pharmacy

Course Curriculum for Master Degree in Clinical Pharmacy Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon

More information

NEOH workshop and 3 rd management committee

NEOH workshop and 3 rd management committee Trans-Domain COST Action TD1404 (NEOH) NEOH workshop and 3 rd management committee Faculdade de Ciências Médicas/Nova Medical School (www.fcm.unl.pt) 18 th and 19 th January 2016 This NEOH workshop (in

More information

TECHNICAL INSIGHTS TECHNOLOGY ALERT

TECHNICAL INSIGHTS TECHNOLOGY ALERT TECHNICAL INSIGHTS TECHNOLOGY ALERT UNLOCKING BREAST CANCER TUMORS' DRUG RESISTANCE A troubling phenomenon in breast cancer treatment is that some patients tumors become resistant to treatments over time.

More information

MRC Technology Centre for Therapeutics Discovery

MRC Technology Centre for Therapeutics Discovery MRC Technology Centre for Therapeutics Discovery fast-tracking discovery and development of novel drugs from academia Dr Duncan Young Business Development Manager UbiFrance Symposium, October 2012 established

More information

Biotechnology Forum 2015

Biotechnology Forum 2015 Biotechnology Forum 2015 WHO Guidelines on scientific principles for regulatory risk assessment of biotherapeutic products Mexico, 23 rd February 2015 Dr Ivana Knezevic, WHO/HIS/EMP 1 Outline WHO International

More information

Issues. Does the academe have as a goal or an obligation, the development of its discoveries for human benefit?

Issues. Does the academe have as a goal or an obligation, the development of its discoveries for human benefit? ELLEN PURÉ, Ph.D. Issues Does the academe have as a goal or an obligation, the development of its discoveries for human benefit? Can the academic review process support individual career development in

More information

PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009

PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 Christelle Dagoneau, PhD Business Development Director Company Profile Protein expert incorporated in 2000

More information

Health Innovation: Future Challenges of Oncology Therapies

Health Innovation: Future Challenges of Oncology Therapies PORTUGUESE ASSOCIATION FOR HOSPITAL DEVELOPMENT Health Innovation: Future Challenges of Oncology Therapies Conclusions. Think Health: The Citizen s Access to Therapeutic Innovation Oncology 8 October 2015

More information

SIPBS Portfolio. 2012-13 Entry

SIPBS Portfolio. 2012-13 Entry SIPBS Portfolio 2012-13 Entry MSc Programmes Existing: MSc Pharmaceutical Analysis MSc Analysis of Medicines (distance learning) MSc Clinical Pharmacy New Programmes just launched for Sept 2012 entry:

More information

3 rd National Conference on Science and Technology

3 rd National Conference on Science and Technology República de Angola Ministério da Ciência e Tecnologia 3 rd National Conference on Science and Technology Conference theme: Science, Technology and Innovation at the service of society 2 nd call Luanda,

More information

Groundbreaking Collaborative Clinical Trial Launched

Groundbreaking Collaborative Clinical Trial Launched Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)

More information

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY 0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PHARMATRAIN CENTRE OF EXCELLENCE EXPLORATORY & CONFIRMATORY CLINICAL DEVELOPMENT: CLINICAL PHARMACOLOGY

More information

Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles

Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles ITMO Neurosciences, sciences cognitives, neurologie, psychiatrie Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles ITMO Technologie pour la santé 1 NEUROSCIENCE MEDICAL CHALLENGES

More information

PUBLIC NOTICE. II - Workplace Faculdade de Ciências da Universidade de Lisboa, located in Campo Grande, 1749-016 Lisboa.

PUBLIC NOTICE. II - Workplace Faculdade de Ciências da Universidade de Lisboa, located in Campo Grande, 1749-016 Lisboa. PUBLIC NOTICE National and international applications are open by Faculdade de Ciências da Universidade de Lisboa (FCUL), for a period of 30 (thirty) working days counted from the day immediately following

More information

THE ECONOMIC AND FINANCIAL CRISIS In EUROPE: On the Road to Recovery? European Lawyers Union XXVII General Congress. Lisbon, 27-29 June 2013

THE ECONOMIC AND FINANCIAL CRISIS In EUROPE: On the Road to Recovery? European Lawyers Union XXVII General Congress. Lisbon, 27-29 June 2013 European Lawyers Union XXVII General Congress THE ECONOMIC AND FINANCIAL CRISIS In EUROPE: On the Road to Recovery? Lisbon, 27-29 June 2013 João Morais Leitão Auditorium Rua Castilho, 165 Friday 28 June

More information

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Tariq Sadat PhD Candidate School of Economics, Finance and Marketing, RMIT University, Australia Roslyn

More information

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from

More information

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5 European Medicines Agency July 1996 CPMP/ICH/140/95 ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NEED FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS

More information

DZIF-Product Development Unit (PDU)

DZIF-Product Development Unit (PDU) November 29, 2013 7 th International VPM Days DZIF-Product Development Unit (PDU) - DZIF-TPMO at HZI - DZIF-OSRA at PEI Thomas Hesterkamp, Helmholtz Zentrum für Infektionsforschung Support from TPMO &

More information

Value of IEEE s Online Collections

Value of IEEE s Online Collections Value of IEEE s Online Collections Judy H. Brady, IEEE Aveiro, Portugal February 2013 About the IEEE A not-for-profit society World s largest technical membership association with over 400,000 members

More information

2 nd Workshop on the Economics of ICTs

2 nd Workshop on the Economics of ICTs 2 nd Workshop on the Economics of ICTs March 31 st and April 1 st 2011 University of Évora Organizers: António Brandão, CEF UP Duarte Brito, CEFAGE UE Andreia Dionísio, CEFAGE UE Pedro Pereira, CMU Portugal

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

What Lies Ahead? Trends to Watch: Health Care Product Development in North America

What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the

More information

Advanced Training and Industrial Research for Complex Engineering Systems, A+

Advanced Training and Industrial Research for Complex Engineering Systems, A+ Advanced Training and Industrial Research for Complex Engineering Systems, A+ A Task Force promoted by, with the Center for Innovation, Technology and Policy Research,, at IST, Lisboa in collaboration

More information

Committing Science to Global Development Award for Best Science Paper

Committing Science to Global Development Award for Best Science Paper Committing Science to Global Development Award for Best Science Paper Ana Ribeiro Abstracts Biodiversity and Agricultural Research Pre-selected by the local cientific commitee: LE + IPAD Award: CGIAR SC

More information

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute

More information

3 Workplace Estoril, at Escola Superior de Hotelaria e Turismo do Estoril (ESHTE). 4 Number of jobs places to be occupied 1 (one).

3 Workplace Estoril, at Escola Superior de Hotelaria e Turismo do Estoril (ESHTE). 4 Number of jobs places to be occupied 1 (one). PUBLIC NOTICE 1 - In accordance with the Career Statute of the Teaching Staff of Polytechnic Higher Education (ECPDESP), approved by Law Decree Nr. 185/81, of July 1st, and amended by Law Decrees Nr. 69/88,

More information

2007: PhD degree in Biology, Instituto de Tecnologia Química e Biológica, New University of Lisbon, Portugal (approved by unanimity)

2007: PhD degree in Biology, Instituto de Tecnologia Química e Biológica, New University of Lisbon, Portugal (approved by unanimity) 1 - Personal data Susana de Sousa Araújo Birth date: 29-08-1976 Nationality: Portuguese Institute address: Centro de Veterinária e Zootecnia do IICT Faculdade de Medicina Veterinária Avenida da Universidade

More information

MSc program Pharmaceutical Design and Engineering. Peter Heegaard, Head of Studies DTU Veterinary

MSc program Pharmaceutical Design and Engineering. Peter Heegaard, Head of Studies DTU Veterinary MSc program Peter Heegaard, Head of Studies DTU Veterinary There is a need for Pharma graduates Pharma industry in its widest sense (see next slide) Research institutions (public and private) Consultants

More information

Pharmaceutical Sciences

Pharmaceutical Sciences Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aapspharmaceutica.com/students How do I know if a career in the pharmaceutical sciences

More information

New Millennium Indian Technology Leadership Initiative

New Millennium Indian Technology Leadership Initiative New Millennium Indian Technology Leadership Initiative A Unique Indian Public-Private Partnership Dr. D. Yogeswara Rao Head Technology Networking and Business Development Division Council of Scientific

More information

1st SEMESTER (beginning in September) Code Course Year ECTS Degree Lecturer Group(s) in English

1st SEMESTER (beginning in September) Code Course Year ECTS Degree Lecturer Group(s) in English 1st SEMESTER (beginning in September) Code Course Year ECTS Degree Lecturer Group(s) in English Level: Bachelor (open to students at all levels) L1805 Marketing Management 1 6 Ralitza Nikolaeva GAi L5004

More information

The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art

The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art GRADUATE PROGRAMS The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art research centers and experiential

More information

Teaching Medicine and Teaching Science: Is there a difference? From MD to PhD (Clinical Researcher) Ines Vaz Luis September 2013

Teaching Medicine and Teaching Science: Is there a difference? From MD to PhD (Clinical Researcher) Ines Vaz Luis September 2013 Teaching Medicine and Teaching Science: Is there a difference? From MD to PhD (Clinical Researcher) Ines Vaz Luis September 2013 Disclosures I have no disclosures But. I have a WARNING: This talk is largely

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

Training programme in pharmaceutical medicine. Project management The basics life cycle, organization and processes

Training programme in pharmaceutical medicine. Project management The basics life cycle, organization and processes Training programme in pharmaceutical medicine Project management The basics life cycle, organization and processes 10 mar - 12 mar 2011 Project management The basics life cycle, organization and processes

More information

Alliance4U - The collaboration initiative to move drug candidates forward

Alliance4U - The collaboration initiative to move drug candidates forward - The collaboration initiative to move drug candidates forward Introduction What are we offering? How? Why apply? Terms Background For grant applications and to attract venture capital start-up companies

More information

Dr Alexander Henzing

Dr Alexander Henzing Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander

More information

School of Pharmacy and Pharmaceutical Sciences: Research. Anne Marie Healy Head of School 04/02/2015

School of Pharmacy and Pharmaceutical Sciences: Research. Anne Marie Healy Head of School 04/02/2015 School of Pharmacy and Pharmaceutical Sciences: Research Anne Marie Healy Head of School 04/02/2015 Pharmaceutical Pharmacists Technologists Pharmacologists Pharmacy Practitioners Pharmaceutical/Medicinal

More information

Transforming relationships Unleashing innovation

Transforming relationships Unleashing innovation Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries

More information

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Fern Barkalow, Ph.D, Senior Analyst, Oncology Citeline One of the biggest challenges facing biosimilar drug developers is

More information

Biotherapeutic Medicines

Biotherapeutic Medicines International Federation of Pharmaceutical Manufacturers & Associations Biotherapeutic Medicines Grasping the New Generation of Treatments Biotherapeutic medicines are an integral and valuable part of

More information

Overview of Phase 1 Oncology Trials of Biologic Therapeutics

Overview of Phase 1 Oncology Trials of Biologic Therapeutics Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of

More information

UT Austin-Portugal launches academic and commercial programs in the emerging technologies field

UT Austin-Portugal launches academic and commercial programs in the emerging technologies field Cooperation Program aims to create more richness for the country UT Austin-Portugal launches academic and commercial programs in the emerging technologies field The UT Austin-Portugal (CoLab) Program,

More information

MASTER IN HISTORY OF THE PORTUGUESE EMPIRE MESTRADO EM HISTÓRIA DO IMPÉRIO PORTUGUÊS (e-learning) 2013/2014

MASTER IN HISTORY OF THE PORTUGUESE EMPIRE MESTRADO EM HISTÓRIA DO IMPÉRIO PORTUGUÊS (e-learning) 2013/2014 MASTER IN HISTORY OF THE PORTUGUESE EMPIRE MESTRADO EM HISTÓRIA DO IMPÉRIO PORTUGUÊS (e-learning) 201/2014 Aim and objectives This master s degree is aimed at students and professionals in various academic

More information

Intensive Course on International Trends in Clinical Quality, Risk Management and Patient Safety: Proven Strategies

Intensive Course on International Trends in Clinical Quality, Risk Management and Patient Safety: Proven Strategies International Trends in Clinical Quality, Risk Management and Patient Safety: Proven Strategies Sponsored by: Sharon Kleefield, Ph.D. Healthcare Quality Director, Harvard Medical International, Lecturer,

More information

LabNT Design Portfolio

LabNT Design Portfolio 2002/2004 Margarida Gaia margarida@isegi.unl.pt April 19th, 2004 www.isegi.unl.pt April 19th, 2004 1 User Friendly The introduction of Design factors in the development of Multimedia Applications and Information

More information

Students from the 1st pgfma with their teachers.

Students from the 1st pgfma with their teachers. Students from the 1st pgfma with their teachers. Gulbenkian Advanced Medical Training Programme The Gulbenkian Advanced Medical Training Programme (pgfma) was set up in 2008, being aimed at fostering and

More information

Pharmacology skills for drug discovery. Why is pharmacology important?

Pharmacology skills for drug discovery. Why is pharmacology important? skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th

More information

ProMeQuaLab. Project of Laboratory Quality Improvement for Portuguese Speaking Countries

ProMeQuaLab. Project of Laboratory Quality Improvement for Portuguese Speaking Countries ProMeQuaLab of Laboratory Quality Improvement for Portuguese Speaking Countries 1 ProMeQuaLab - of Laboratory Quality Improvement for Portuguese Speaking Countries Cape Verde Guinea Bissau Equatorial Guinea

More information

PEnPAL - Portuguese - English Platform of Anthologies of Literature in Translation

PEnPAL - Portuguese - English Platform of Anthologies of Literature in Translation University of Lisbon Centre for English Studies Centro de Estudos Anglísticos da Universidade de Lisboa PEnPAL - Portuguese - English Platform of Anthologies of Literature in Translation January 16, 2015

More information

8:50 Opening statement - Dr. Felipe José Fernández Coimbra (Head of the Department of Abdominal Surgery, Hospital A. C.

8:50 Opening statement - Dr. Felipe José Fernández Coimbra (Head of the Department of Abdominal Surgery, Hospital A. C. IV SYMPOSIUM OF THE GASTROINTESTINAL ONCOLOGY CONTINUING MEDICAL EDUCATION PROGRAM - DEPARTMENT OF ABDOMINAL SURGERY, SURGICAL ONCOLOGY, A. C. CAMARGO CANCER HOSPITAL ESOPHAGOGASTRIC CANCER AND GIST SCIENTIFIC

More information

1st International Conference Porto as a Tourism Destination: City Tourism. Almeida Garrett Municipal Library Auditorium, Porto - Portugal

1st International Conference Porto as a Tourism Destination: City Tourism. Almeida Garrett Municipal Library Auditorium, Porto - Portugal 1st International Conference Porto as a Tourism Destination: City Tourism 26 to 28 September, 2013 Almeida Garrett Municipal Library Auditorium, Porto - Portugal PROGRAMME September 26 (Thursday) 9h00:

More information

Pre-market Information - Class III and IV

Pre-market Information - Class III and IV Pre-market Information - Class III and IV Life Sciences Council British Columbia NRC Industry Research Assistance Program Vancouver, October 29, 2007 Mary-Jane Bell, Ph.D. Medical Devices Bureau (MDB)

More information

HSA Consumer Guide. Understanding Vaccines, Vaccine Development and Production. www.hsa.gov.sg November 2009. How a Vaccine Works.

HSA Consumer Guide. Understanding Vaccines, Vaccine Development and Production. www.hsa.gov.sg November 2009. How a Vaccine Works. November 2009 Understanding Vaccines, Vaccine Development and Production Vaccines, in general, help protect people from harmful infections before they come in contact with the disease. Vaccines may also

More information